ReAlta Life Sciences - Biotechnology - $55M Raised, Reviews & Alternatives

StartupHub.ai

ReAlta Life Sciences

Developing novel therapeutics for inflammatory and hypoxic diseases.

Website

2016ActiveNorfolk, USA

About

ReAlta Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory and hypoxic diseases. Their lead candidate, Pegtarazimod, is being investigated for Hypoxic Ischemic Encephalopathy (HIE). The company leverages its proprietary platform to discover and develop treatments for a range of serious medical conditions. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.

Alternatives to ReAlta Life Sciences

View all

Moderna

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Degron Therapeutics

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Epicrispr Biotechnologies

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Adcendo

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Compare ReAlta Life Sciences

View all →

Scores

Measured, not editorial

Agent Readiness

25/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Scan this site yourself How to improve

Site Speed

100/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Open in PageSpeed Insights

Add first review